Exchange: OTC·Updated 03:38 PM EST

About OTLC

About

Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
56

Frequently Asked Questions

Advertisement|Remove ads.